ABSTRACT
Prone positioning ventilation (PPV) is considered one of the essential therapeutic approaches in the management of acute respiratory distress syndrome (ARDS). Several randomized controlled clinical trials have demonstrated the efficacy of PPV in the treatment of patients with ARDS. However, it is not clear whether PPV treatment can reduce mortality in patients with veno-venous extracorporeal membrane oxygenation (VV-ECMO)-supported ARDS and corona virus disease 2019 (COVID-19)-associated ARDS. This review aims to discuss the known and unknown aspects of the mechanism of PPV for ARDS, the clinical efficacy of PPV for ARDS, VV-ECMO-supported ARDS, and COVID-19-related ARDS.
Subject(s)
COVID-19 , Respiratory Distress Syndrome , Humans , Prone Position , Respiration, Artificial , Treatment Outcome , Respiratory Distress Syndrome/therapyABSTRACT
OBJECTIVE: To observe the effect of Gastrodia on motion sickness induced by rotation in mice. METHOD: Clockwise and anticlockwise accelerated rotations up to 180 degrees/s for 10 min were used to induce symptoms of motion sickness such as condition taste aversion (CTA), decrease of spontaneous locomotion and impaired ability of space identification in water-maze. RESULT: Gastrodia could improve the response of CTA, increase spontaneous locomotion, and enhance the ability of learning and memory in water-maze in mice after the rotation. CONCLUSION: Symptoms of motion sickness induced by rotation could be improved by Gastrodia treatment.
